A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION

Abstract. This study was conducted to develop a predictive model including routinely available laboratory tests to reflect the histological liver fibrosis stage in patients with chronic hepatitis virus infection (HVI). The «training» (preliminary) cohort included 37 healthy volunteers without liver...

Full description

Bibliographic Details
Main Authors: A. A. Ostanin, E. L. Gelfgadt, M. V. Shipunov, E. Ya. Shevela, E. V. Kurganova, L. A. Khvan, A. I. Paltzev, N. M. Starostina, E. R. Chernykh
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/200
_version_ 1826534339898245120
author A. A. Ostanin
E. L. Gelfgadt
M. V. Shipunov
E. Ya. Shevela
E. V. Kurganova
L. A. Khvan
A. I. Paltzev
N. M. Starostina
E. R. Chernykh
author_facet A. A. Ostanin
E. L. Gelfgadt
M. V. Shipunov
E. Ya. Shevela
E. V. Kurganova
L. A. Khvan
A. I. Paltzev
N. M. Starostina
E. R. Chernykh
author_sort A. A. Ostanin
collection DOAJ
description Abstract. This study was conducted to develop a predictive model including routinely available laboratory tests to reflect the histological liver fibrosis stage in patients with chronic hepatitis virus infection (HVI). The «training» (preliminary) cohort included 37 healthy volunteers without liver fibrosis (F0) and 126 patients with minimal (F1/2, n = 40) and significant/advanced (F3, n = 39) fibrosis and histological cirrhosis (F4, n = 47). It was revealed that several routine clinical/biochemical parameters (erythrocyte sedimentation rate, platelet count, prothrombin time [PT], serum level of albumin [Alb], bilirubin, aspartate aminotransferase [AST], thymol test) and immunological features (IgA, IgG) as well special fibrosis markers (ММР-9, TIMP-1) significantly correlated with severity of liver fibrosis (Spearman’s rank correlation coefficient 0.45-0.69; p < 0.0001). To select predictive factors contributing to discrimination of the fibrosis stage, we performed a stepwise logistic multivariate regression of the laboratory variables in F1/2 vs F3, and F3 vs F4 patients, respectively. Based on the multiple regression model, we derived a novel Integral Index of Fibrosis (IIF) defined by five biochemical parameters (PT, glucose, Alb, AST, lactate dehydrogenase). IIF was applied to the validation cohort comprised of 84 patients with chronic HVI (F1/2 n = 42; F3 n = 19; F4 n = 23) to test its diagnostic accuracy. Corresponding values of IIF allow a reliable prediction of fibrosis stages (F1/2 vs F3 vs F4) with a diagnostic accuracy of 86%; with a positive predictive value (PPV is the percentage of positive tests that are truly positive) of 94%; and with a negative predictive value (NPV is the percentage of negative tests that are truly negative) of 91.7%. In conclusion, our study showed that the Integral Index of Fibrosis consisting of five routinely available laboratory tests provides clinically useful information regarding different liver fib rosis stages among patients with chronic hepatitis virus infection. (Med. Immunol., vol. 10, N 4-5, pp 405-414).
first_indexed 2024-03-08T05:51:51Z
format Article
id doaj.art-a742e3f4c9224f94ae92fbbf80a88bb6
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2025-03-14T02:21:27Z
publishDate 2014-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-a742e3f4c9224f94ae92fbbf80a88bb62025-03-11T17:59:01ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-07-01104-540541410.15789/1563-0625-2008-4-5-405-414197A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTIONA. A. Ostanin0E. L. Gelfgadt1M. V. Shipunov2E. Ya. Shevela3E. V. Kurganova4L. A. Khvan5A. I. Paltzev6N. M. Starostina7E. R. Chernykh8ГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскГУ НИИ клинической иммунологии СО РАМН, г. НовосибирскAbstract. This study was conducted to develop a predictive model including routinely available laboratory tests to reflect the histological liver fibrosis stage in patients with chronic hepatitis virus infection (HVI). The «training» (preliminary) cohort included 37 healthy volunteers without liver fibrosis (F0) and 126 patients with minimal (F1/2, n = 40) and significant/advanced (F3, n = 39) fibrosis and histological cirrhosis (F4, n = 47). It was revealed that several routine clinical/biochemical parameters (erythrocyte sedimentation rate, platelet count, prothrombin time [PT], serum level of albumin [Alb], bilirubin, aspartate aminotransferase [AST], thymol test) and immunological features (IgA, IgG) as well special fibrosis markers (ММР-9, TIMP-1) significantly correlated with severity of liver fibrosis (Spearman’s rank correlation coefficient 0.45-0.69; p < 0.0001). To select predictive factors contributing to discrimination of the fibrosis stage, we performed a stepwise logistic multivariate regression of the laboratory variables in F1/2 vs F3, and F3 vs F4 patients, respectively. Based on the multiple regression model, we derived a novel Integral Index of Fibrosis (IIF) defined by five biochemical parameters (PT, glucose, Alb, AST, lactate dehydrogenase). IIF was applied to the validation cohort comprised of 84 patients with chronic HVI (F1/2 n = 42; F3 n = 19; F4 n = 23) to test its diagnostic accuracy. Corresponding values of IIF allow a reliable prediction of fibrosis stages (F1/2 vs F3 vs F4) with a diagnostic accuracy of 86%; with a positive predictive value (PPV is the percentage of positive tests that are truly positive) of 94%; and with a negative predictive value (NPV is the percentage of negative tests that are truly negative) of 91.7%. In conclusion, our study showed that the Integral Index of Fibrosis consisting of five routinely available laboratory tests provides clinically useful information regarding different liver fib rosis stages among patients with chronic hepatitis virus infection. (Med. Immunol., vol. 10, N 4-5, pp 405-414).https://www.mimmun.ru/mimmun/article/view/200chronic hepatitis virus infectionliver fibrosis stagefibrosis markersmmp-9timp-1
spellingShingle A. A. Ostanin
E. L. Gelfgadt
M. V. Shipunov
E. Ya. Shevela
E. V. Kurganova
L. A. Khvan
A. I. Paltzev
N. M. Starostina
E. R. Chernykh
A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
Медицинская иммунология
chronic hepatitis virus infection
liver fibrosis stage
fibrosis markers
mmp-9
timp-1
title A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
title_full A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
title_fullStr A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
title_full_unstemmed A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
title_short A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
title_sort predictive model for non invasive evaluation of liver fibrosis in patients with chronic hepatitis virus infection
topic chronic hepatitis virus infection
liver fibrosis stage
fibrosis markers
mmp-9
timp-1
url https://www.mimmun.ru/mimmun/article/view/200
work_keys_str_mv AT aaostanin apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT elgelfgadt apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT mvshipunov apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT eyashevela apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT evkurganova apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT lakhvan apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT aipaltzev apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT nmstarostina apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT erchernykh apredictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT aaostanin predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT elgelfgadt predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT mvshipunov predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT eyashevela predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT evkurganova predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT lakhvan predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT aipaltzev predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT nmstarostina predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection
AT erchernykh predictivemodelfornoninvasiveevaluationofliverfibrosisinpatientswithchronichepatitisvirusinfection